The SITC 2017 Microlearning: Toxicities Series has been developed with content from abstract and faculty presentations conducted at the Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017). The microlearning series provide a quick, easily accessible format for clinicians and researchers to learn about the latest advances in cancer immunotherapy from experts in the field.
The Toxicities series contains three modules.
Module 1: Antibody-Mediated Neutralization of Soluble MIC Significantly Enhances Response to CTLA4 Blockade and Reduces Therapy-Induced Colitis
Jennifer Wu, PhD - Northwestern University
Module 2: Pharmacological Management of irAEs
Nathan Dahl, PharmD, R.Ph, BCOP - Clovis Oncology
Module 3: Variance from Evidence-Based Management of Immune-Related Adverse Events Among Healthcare Providers: Analysis of an Online Management Decision Tool
Krista Marcello, BA - Clinical Care Options, LLC
These modules have been designed to meet the educational needs of researchers and healthcare professionals involved in cancer research and clinical care.
Course Available Beginning: August 16, 2018
Course Objectives Upon completion of this activity, participants will be able to:
Understand how immunotherapies can cause unique toxicities.
Recognize symptoms of immune-related adverse events.
Describe optimal management of immune-related toxicities.
The SITC connectED education portal is supported by independent educational grants from AstraZeneca Pharmaceuticals LP and Merck & Co., Inc.
Cookies are small pieces of information that are stored by your browser on your computerâ€™s hard drive.
You can delete or block cookies within your browser settings.
Should you opt to do this, some parts of our site may not work.
For more information, including instructions on how to remove the cookies that have been placed,